ArticleBritish journal of haematology2021

Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low-intensity chemotherapy in acute myeloid leukaemia.

Ing S Tiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.